← All trials
NCT05340621
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 11, 2022
- Primary completion
- Mar 4, 2026
- Completion date
- Apr 4, 2026
- First posted
- Apr 22, 2022
- Last posted
- Sep 26, 2022
- Enrollment
- 73
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- OnKure, Inc.Lead sponsor
- Harvard UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.